Regulatory November 7, 2025 Vivesto reports positive interim results for Paccal Vet pilot study in dogs
Regulatory November 7, 2025 Nomination Committee appointed for the Annual General Meeting 2026 in Vivesto
Regulatory March 31, 2025 Vivesto signs deal with Kazia Therapeutics to acquire full Cantrixil rights
